Anticoagulant Utilization and Direct Oral Anticoagulant Prescribing in Patients with Nonvalvular Atrial Fibrillation

A Prospective Protocol Increases Oral Anticoagulant Prescription in Patients With Chronic, Nonvalvular Atrial Fibrillation

Rev Esp Cardiol 2003;56(10):971-7 97

Factors Influencing Oral Anticoagulant Prescribing Practices for Atrial Fibrillation

[A prospective protocol increases oral anticoagulant prescription in patients with chronic, nonvalvular atrial fibrillation].

INTRODUCTION AND OBJECTIVES Observational studies have shown that oral anticoagulants (OAC) prescription is suboptimal in patients with nonvalvular atrial fibrillation (NVAF). Our objective was to evaluate the usefulness of a prospective protocol for increasing OAC usage in these patients. PATIENTS AND METHOD From 1 February 2000 until 31 October 2002 we enrolled all patients with chronic NVA...

Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation

Despite the availability of predictive tools and treatment guidelines, anticoagulant therapies are underprescribed and many patients are undertreated for conditions that predispose to thromboembolic complications, including stroke. This review explores reasons for which physicians fear that the risks of anticoagulation may be greater than the potential benefit. The results of numerous clinical ...

Comparative Assessment of the Anticoagulant Activity of Rivaroxaban and Dabigatran in Patients With Nonvalvular Atrial Fibrillation

There is a shortage of data in everyday clinical practice about the anticoagulant effects caused by the new oral anticoagulants (NOAs). Our aim was to estimate the intensity of anticoagulant activity induced by rivaroxaban 20 mg qd and dabigatran 110 mg bid among patients with nonvalvular atrial fibrillation (NV-AF).We studied 20 patients with NV-AF treated with dabigatran, and 20 patients trea...